The American Society for Pharmacy Law (ASPL) is an organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties.

ASPL is a non-profit which encourages diversity & inclusion with the Society, regardless of differing backgrounds, perspectives, experiences, orientations, origins, and practice settings. The Society embraces participation and diversity as it leads to advancing our purpose: 

  • Furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues;
  • Communicating accurate legal educational information; and
  • Providing educational opportunities for pharmacists, attorneys, and others who are interested in pharmacy law

Latest News

September 26, 2023

MEDICATION BELIEVED TO FACILITATE WEIGHT LOSS IS FOCUS OF TEN LAWSUITS FILED BY ELI LILLY & COMPANY 

September 19 brought to lawsuits filed by the pharmaceutical manufacturer in seven different U.S. District Courts alleging trademark infringement and other legal transgressions. Four of the suits were against compounding pharmacies in Florida and Texas while the six others are against spas and other retailers alleged to be selling counterfeit or compounded versions of the medication. The spa-focused suits allege trademark infringement while the pharmacy matters are rooted in state-level drug product control statutes and/or unfair competition legislation.

[Karpan A. Eli Lilly Launches 10 Suits Over New Diabetes Drug. LAW360, September 19, 2023, https://www.law360.com/articles/1723376/print?section=competition; Wingrove P. Eli Lilly Sues Over US Sales of Bogus Mounjardo for Weight Loss. Reuters, September 19, 2023, https://reuters.com/legal/eli-lilly-sues-over-us-sales-bogus-mounjardo-weight-loss-2023-09-19/]